Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jingxian Pei"'
Autor:
Shenghui Zhang, Cheng Liu, Pingsheng Wu, Hu Li, Yingyuan Zhang, Kaiwei Feng, Huiling Huang, Jinxia Zhang, Yanxian Lai, Jingxian Pei, Zhang Lu, Junfang Zhan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 20 (2024)
Background The aim of this study was to characterize the burden of valvular heart disease (VHD)‐related heart failure (HF) in Group of 20 (G20) countries. Methods and Results Using data from the 2019 Global Burden of Disease Study, we estimated VHD
Externí odkaz:
https://doaj.org/article/d41feffcaaae454cbee88a98e9abb014
Autor:
Shenghui Zhang, Cheng Liu, Yingyuan Zhang, Zongjian Wu, Kaiwei Feng, Yanxian Lai, Jingxian Pei, Tianwang Guan
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Valvular heart disease (VHD)-related heart failure (HF) is a special subtype of HF with an increasingly concerned heterogeneity in pathophysiology, clinical phenotypes, and outcomes. The mechanism of VHD-related HF involves not only mechanical damage
Externí odkaz:
https://doaj.org/article/a546ea16428840aab0cccf14ec0b10db
Autor:
Cheng Liu, Jingxian Pei, Yanxian Lai, Tianwang Guan, Abudurexiti Zeyaweiding, Tutiguli Maimaiti, Haiyan Zhao, Yan Shen
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Atrial fibrillation (AF) is the most common cardiac arrhythmia. Type 2 diabetes (T2D) is an independent risk factor for AF. The cardioembolic stroke (CS) risk is increased when both conditions coexist. Whether angiotensin-converti
Externí odkaz:
https://doaj.org/article/bc4b16274a66490989548d785dcdddbc
Autor:
Cheng Liu, Yanxian Lai, Tianwang Guan, Junfang Zhan, Jingxian Pei, Daihong Wu, Songsong Ying, Yan Shen
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Type 2 diabetes (T2D) is characterized by increased levels of blood glucose but is increasingly recognized as a heterogeneous disease, especially its multiple discrete cardiovascular phenotypes. Genetic variations play key roles in the heterogeneity
Externí odkaz:
https://doaj.org/article/08bbab33118344b582e60cc0c70bb082
Autor:
Cheng Liu, Yanxian Lai, Tianwang Guan, Qingchun Zeng, Jingxian Pei, Shenghui Zhang, Daihong Wu, Deping Wu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Objective: This retrospective, case–control study was executed to assess the effects of digoxin (DGX) use approaches [continuous use of DGX (cDGX) vs. intermittent use of DGX (iDGX)] on the long-term prognosis in rheumatic heart disease (RHD) patie
Externí odkaz:
https://doaj.org/article/aa450ccccda9457d921c2968d471d7d7
Autor:
Mingyan Li, Yongsheng Cui, Wenkai He, Xiufang Deng, Yuting Wang, Meifeng Cai, Yuegang Wang, Jingxian Pei, Xiao Mei, Pingsheng Wu
Publikováno v:
Cellular Physiology and Biochemistry, Vol 50, Iss 6, Pp 2329-2340 (2018)
Background/Aims: The effects of hypoxia-inducible factor-1α (HIF-1α) on angiogenesis and cardiac function improvement in rats with myocardial infarction (MI) is unknown and our current study was to evaluate whether HIF-1α would be beneficial for a
Externí odkaz:
https://doaj.org/article/047dec4256a64af881b8b887b401e577
Publikováno v:
The Journal of clinical endocrinology and metabolism.
Context Refractory angina pectoris (RAP) is a specific subtype of coronary artery disease (CAD). Lipoprotein(a) [Lp(a)] and its induced coronary microvascular dysfunction (CMD) play an important role in pathogenesis of RAP, but its metabolism was mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3528feb292d57fcb2ec94fd3e5474afc
https://pubmed.ncbi.nlm.nih.gov/36469795
https://pubmed.ncbi.nlm.nih.gov/36469795
Autor:
Tianwang Guan, Yan Shen, Cheng Liu, Haiyan Zhao, Jingxian Pei, Abudurexiti Zeyaweiding, Yanxian Lai, Tutiguli Maimaiti
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Atrial fibrillation (AF) is the most common cardiac arrhythmia. Type 2 diabetes (T2D) is an independent risk factor for AF. The cardioembolic stroke (CS) risk is increased when both conditions coexist. Whether angiotensin-converting enzyme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f90ea58952d90bbec3c64dc1ff038307
https://doaj.org/article/bc4b16274a66490989548d785dcdddbc
https://doaj.org/article/bc4b16274a66490989548d785dcdddbc
Publikováno v:
Journal of Clinical Endocrinology & Metabolism; May2023, Vol. 108 Issue 5, p1061-1074, 14p
Autor:
Cheng Liu, Yanxian Lai, Tianwang Guan, Junfang Zhan, Jingxian Pei, Daihong Wu, Songsong Ying, Yan Shen
Publikováno v:
Frontiers in cardiovascular medicine. 9
Type 2 diabetes (T2D) is characterized by increased levels of blood glucose but is increasingly recognized as a heterogeneous disease, especially its multiple discrete cardiovascular phenotypes. Genetic variations play key roles in the heterogeneity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::822b4578c2c68b33f15aa270d3be6c1c
https://pubmed.ncbi.nlm.nih.gov/35402560
https://pubmed.ncbi.nlm.nih.gov/35402560